Money Matters - Simplified

breast cancer

Artificial 'Brain' to diagnose breast cancer programmed by a high school junior girl

An artificial “brain” built by a 17-year-old whiz kid from Florida is able to accurately assess tissue samples for signs of breast cancer. The cloud-based neural network took top prize in this year’s Google Science Fair.

Breast screening plays little role in cutting mortality - study

Routine breast cancer screening programmes have little impact on the falling death rates from the disease, researchers said on Friday.

Vitamin D halves breast cancer risk-study

Increase in breast cancer cases among women has been a major cause of concern worldwide.

Less educated Americans encounter higher cancer risks—study

The American Cancer Society’s annual cancer report unveiled Friday reveals that less educated Americans confront higher cancer risks as compared to their educated counterparts.

Alcohol ups cancer risk--study

According to the new European study published in the 'British Medical Journal,' consumption of more than two alcoholic drinks a day by men and one drink by women can raise the risks of cancer.

FDA grants hearing to Genentech over breast cancer drug

Genentech, a Roche subsidiary, has been informed through a letter by the Food and Drug Administration (FDA) that the federal agency is ready to give another chance to the company to argue in favour of of ‘Avastin’ a drug for breast cancer.

Gum disease ups breast cancer risk--study

Women may be at greater risk of breast cancer if they have gum disease or missing teeth, according to the findings of a recent study.

Heavy smoking ups breast cancer risk--study

Here's another reason why women should quit smoking. Apart from causing heart attack or lung cancer, puffing the smoke increases breast cancer risk.

Zoledronic acid exhibits no benefits in breast cancer therapy--study

Contrary to expectations that zoledronic acid, an osteoporosis drug, marketed under the brand name Zometa would improve survival and recurrence rates for women with early stage breast cancer, the results of a recent clinical trial found it exhibited no benefits as an anti-cancer drug.

CDC report finds most cancers spotted in last stage

Though advanced screening solutions are readily available, too many cancers are still diagnosed at an advanced stage which makes treatment of the lethal disease all the more difficult.